ABILDGAARD OLE enters LUNAI BIOWORKS INC. with 3.47M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 10/6/2023ACC: 0001013762-23-002552
3.47M
Baseline shares
0% direct
5K
Direct ownership
1 position
6.70M
Derivative underlying
4 instruments
2
Security positions
3.46M indirect
Non-Derivative Holdings2
Common Stock
IndirectShares owned3.46M
Common Stock
DirectShares owned5K
Total
5K direct·3.46M indirect3.47M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.46M | Indirect |
| Common Stock | 5K | Direct |
| Total | 3.47M | 5K direct·3.46M indirect |
Derivative Holdings4
Warrants (right to buy)
IndirectUnderlying security
Common Stock
Underlying shares
1.72M
Shares owned
N/A
Exercise price
0.65
Expiration
—
Exercise window
—
Series A Convertible Preferred Stock
IndirectUnderlying security
Common Stock
Underlying shares
3.44M
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Warrants (right to buy)
IndirectUnderlying security
Common Stock
Underlying shares
125K
Shares owned
N/A
Exercise price
1.14
Expiration
—
Exercise window
—
Warrants (right to buy)
IndirectUnderlying security
Common Stock
Underlying shares
1.42M
Shares owned
N/A
Exercise price
0.53
Expiration
—
Exercise window
—
Total
Underlying
6.70M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrants (right to buy) Indirect | Common Stock | 0.65 | — | — | 1.72M | N/A |
| Series A Convertible Preferred Stock Indirect | Common Stock | 0 | — | — | 3.44M | N/A |
| Warrants (right to buy) Indirect | Common Stock | 1.14 | — | — | 125K | N/A |
| Warrants (right to buy) Indirect | Common Stock | 0.53 | — | — | 1.42M | N/A |
| Total | 6.70M | 0.00 | ||||